Indy Hematology Review

http://www.indyhematologyreview.com/

 

Indy Hematology Review
Avatar

Jak2 inhibitor therapy for Essential thrombocythemia : MAJIC Study

By Indy Hematology Review FEATURING John Mascarenhas
By Indy Hematology Review FEATURING John Mascarenhas
135 views
May 16, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Featured Video

19:25
Pfizer Hematology

Moving Forward in Stage III/IV Classical Hodgkin Lymphoma

Feat. A. Ip
MPN
10:54

Jak2 inhibitor therapy for Polychthemia Vera

Indy Hematology Review

J. Mascarenhas

145 views
01:57

Jak2 inhibitor therapy for Essential thrombocythemia : MAJIC Study

Indy Hematology Review

J. Mascarenhas

135 views
05:14

Jak2 Inhibitors in Myelofibrosis

Indy Hematology Review

J. Mascarenhas

232 views
02:58

Ruxolitinib based combination therapy in MPN

Indy Hematology Review

J. Mascarenhas

129 views
03:57

JAK2 inhibitors in MPN questions

Indy Hematology Review

J. Mascarenhas

119 views
06:50

Intro to Myeloproliferative Neoplasms Classification

Indy Hematology Review

A. Tefferi

33 views
05:35

Intro to practical diagnostic algorithm for Myeloproliferative neopl…

Indy Hematology Review

A. Tefferi

26 views
09:29

Intro to treatment algorithm for Myeloproliferative Neoplasms

Indy Hematology Review

A. Tefferi

52 views